| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| DSP Global Innovation Overseas Equity Omni FoF (G) Direct |
| [Equity: Global] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.17 |
| Int Equity |
96.46 |
| Trep |
3.71 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
93.96% |
| Top 10 Holdings |
100.00% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Global Equity |
96.46 |
| Cash |
3.54 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
0.00 |
| PE Ratio |
0.00 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Bluebox Global Technology Fund |
40.20 |
| iShares NASDAQ 100 UCITS ETF |
28.14 |
| Invesco NASDAQ-100 Equal Weight UCITS ETF |
12.53 |
| KraneShares CSI China Internet ETF |
9.34 |
| Fidelity Select Medical Technology And Devices Portfolio |
3.75 |
| TREPS / Reverse Repo Investments |
3.71 |
| Bluebox Precision Medicine Fund |
2.50 |
| Net Receivables/Payables |
-0.17 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|